Androgen receptor signaling affects the response to targeted therapy in people with melanoma
Androgen receptor (AR) signaling affects response to BRAF / MEK inhibitor therapy in both men and women with melanoma, researchers at the University of Texas MD Anderson Cancer Center showed in a study published today a Nature. The findings provide a new target for combating therapeutic resistance and a possible answer to why men face …